21a. Gray J. A., Feldon J., Rawlins J. N. P., Hemsley D. R. and Smith A. D. (1991) The neuropsychology of schizophrenia.
Behav. Brain Sci. 14, 1–84.
21. Graybiel A. M. (1990) Neurotransmitters and neuromodulation in the basal ganglia. Trends Neurosci. 13, 244–258.
22. GriYths M. R., Stockwell T., Barber D. J., Cooper A. J. and Mitchell I. J. (1997) Striatal apoptosis induced by acute
administration of phencyclidine is potentiated by coadministration of dexamethasone. Brain Res. Assoc. Abstr. 14,
75.
23. Hamamura T., Ichimara Y. and Fibiger H. C. (1997) Amphetamine sensitization enhances regional c-fos expression
produced by conditioned fear. Neuroscience 76, 1097–1103.
24. Handa R. J., Nunley K. M. and Bollnow M. R. (1993) Induction of c-fos mRNA in the brain and anterior pituitary
gland by a novel environment. NeuroReport 4, 1079–1082.
25. Harrison M. B., Wiley R. G. and Wooten G. E. (1990) Selective localization of striatal D receptors to striatonigral
1

neurons. Brain Res. 528, 317–322.
26. Hashimoto K., Tomitaka S., Narita N., Minabe Y., Iyo M. and Fukui S. (1996) Induction of heat shock protien
(HSP)-70 in posterior cingulate and retrosplenial cortex of rat brain by dizocilpine and phencyclidine: lack of
protective eVects of sigma receptor ligands. Addict. Biol. 1, 61–70.
27. Hastings T. G., Lewis D. A. and Zigmond M. J. (1996) Role of oxidation in the neurotoxic eVects of intrastriatal
dopamine injections. Proc. natn. Acad. Sci. U.S.A. 93, 1956–1961.
28. Hedreen J. C. and Folstein S. E. (1995) Early loss of neostriatal striosome neurons in Huntington's disease.
J. Neuropath. exp. Neurol. 54, 105–120.
29. Ismail K. and Wessely S. (1995) Psychiatric complications of corticosteroid therapy. Br. J. Hospital Med. 53,
495–499.
29a. Iversen S. D. (1995) Interactions between excitatory amino acids and dopamine systems in the forebrain: implications
for schizophrenia and Parkinson's disease. Behav. Pharmac. 6, 478–491.
30. Jackson D. M., Johansson C., Lindgren L. I. and Bengstsson A. (1994) Dopamine receptor antagonists block
amphetamine and phencyclidine-induced motor stimulation in rats. Pharmac. Biochem. Behav. 48, 465–471.
31. JeVcoate W. J., Silverstone J. T., Edwards C. R. W. and Besser G. M. (1979) Psychiatric manifestations of Cushing's
syndrome: response to lowering of plasma cortisol. Q. Jl med. N.S. 48, 465–472.
31a. Landwehrmeyer G. B., Standaert D. G., Testa C. M., Penney J. B. and Young A. B. (1995) NMDA receptor subunit
mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15, 5297–5307.
31b. Lillrank S. M., O'Connor W. T., Saransaari P. and Ungerstedt U. (1994) In vivo eVects of local and systemic
phencyclidine on the extracellular levels of catecholamines and transmitter amino acids in the dorsolateral striatum of
anaesthetized rats. Acta physiol. scand. 150, 109–115.
32. Kawaguchi Y., Wilson C. J., Augood S. J. and Emson P. C. (1995) Striatal interneurons: chemical, physiological and
morphological characterization. Trends Neurosci. 18, 527–535.
33. Kelley A. E., Delfs J. M. and Chu B. (1990) Neurotoxicity induced by the D-1 agonist SKF38393 following
microinjection into rat brain. Brain Res. 532, 342–346.
34. Mazars G. (1970) Criteria for identifying cingulate epilepsies. Epilepsia 11, 41–47.
35. McGeorge A. J. and Faull R. L. M. (1989) The organisation of the projection from the cerebral cortex to the striatum
in the rat. Neuroscience 29, 503–537.
36. Mena M. A., Pardo B., Casarejos M. J., Fahn S. and Yebenes J. G. (1992) Neurotoxicity of levodopa on
catecholamine-rich neurons. Movement Disord. 7, 23–31.
37. Mitchell I. J., Jackson A., Sambrook M. A. and Crossman A. R. (1989) The role of the subthalamic nucleus in
experimental chorea: evidence from 2-deoxyglucose metabolic studies and horseradish peroxidase tracing studies.
Brain 112, 1533–1548.
38. Mitchell I. J., Lawson S., Moser B., Laidlaw S. M., Cooper A. J., Walkinshaw G. and Waters C. M. (1994)
Glutamate-induced apoptosis results in a loss of striatal neurons in the Parkinsonian rat. Neuroscience 63, 1–5.
39. Nakki R., Koistinaho J., Sharp F. R. and Sagar S. M. (1995) Cerebellar toxicity of phencyclidine. J. Neurosci. 15,
2097–2108.
40. Nishijima K., Kashiwa A., Hashimoto A., Iwama H., Umino A. and Nishikawa T. (1996) DiVerential eVects of
phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo
dialysis. Synapse 22, 303–312.
41. Norman R. M. G. and Malla A. K. (1993) Stressful life events and schizophrenia I: A review of the research. Br.
J. Psychiat. 162, 161–166.
42. Nuechterlein K. H. and Dawson M. E. (1984) A heuristic vulnerability-stress model of schizophrenic episodes.
Schizophr. Bull. 10, 300–312.
43. Olney J. W., Labruyere J., Wang G., Wozniak D. F., Price M. T. and Sesma M. A. (1991) NMDA antagonist
neurotoxicity: mechanism and prevention. Science 254, 1515–1518.
44. Oorschot D. E. (1996) Total number of neurons in the neostriatal, pallidal, subthalamic and substantia nigra nuclei of
the rat basal ganglia: a stereological study using the Cavalieri and optical disector methods. J. comp. Neurol. 366,
580–599.
45. Pauly J. R., Robinson S. F. and Collins A. C. (1993) Chronic corticosterone administration enhances behavioural
sensitization to amphetamine in mice. Brain Res. 620, 195–202.
46. Price L. H., Spencer D. D., Marek K. L., Robbins R. J., Leranth C., Farhi A., Naftolin F., Roth R. H., Bunney B.
S., HoVer P. B., Makuch R. and Redmond D. E. (1995) Psychiatric status after human fetal mesencephalic tissue
transplantation in Parkinson's disease. Biol. Psychiat. 8, 498–505.
47. RaV M. C., Barres B. A., Burne J. F., Coles H. S., Ishizaki Y. and Jacobson M. D. (1993) Programmed cell death and
the control of cell survival: lesson from the nervous system. Science 262, 695–700.
48. Reiner A., Albin R. L., Anderson K. D., D'Amato C. J., Penney J. B. and Young A. B. (1988) DiVerential loss of
striatal projection neurons in Huntington's disease. Proc. natn. Acad. Sci. U.S.A. 85, 5733–5737.
49. Rots N. Y., Cools A. R., Dejong J. and Dekloet E. R. (1995) Corticosteroid feedback resistance in rats genetically
selected for increased dopamine responsiveness. J. Neuroendocr. 7, 153–161.
